A metabolic switch triggers inflammatory cell death in rheumatoid arthritis
A new study in *Immunity* reveals a critical mechanism driving chronic inflammation in rheumatoid arthritis, centered on macrophage metabolism and a novel form of cell death. Researchers found that homeostatic macrophages within arthritic joints, which typically have reparative potential, undergo metabolic exhaustion and a process called PANoptosis. The mechanism is initiated by the complement protein C1q, which activates the mitochondrial enzyme SARM1. This activation cleaves NAD⁺ into cyclic ADP-ribose (cADPR), leading to a catastrophic metabolic collapse. The subsequent death of these macrophages releases a cascade of pro-inflammatory mediators, perpetuating autoimmune tissue damage and inflammation. This research provides a direct link between metabolic dysfunction, a specific cell death pathway, and the persistence of inflammatory disease.
Study Significance: This finding shifts the understanding of chronic inflammation from a focus solely on immune cell activation to include metabolic failure as a key driver of pathology. For researchers in cell biology and immunology, it identifies SARM1 and NAD⁺ metabolism as potential high-value therapeutic targets for interrupting the inflammatory cycle in autoimmune diseases. The study underscores the importance of investigating metabolic pathways within specific immune cell populations to develop more precise anti-inflammatory strategies.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
